Atlas Antibodies is a biotechnology company based in Stockholm that specializes in protein research and analysis. The company is known for its advanced multiplexing techniques and a strong focus on proximity ligation technology, which enhances the ability to study protein interactions and functions. By collaborating with researchers and clinicians, Atlas Antibodies supports next-generation protein analysis, contributing to a deeper understanding of biological processes.
The company is rooted in the Human Protein Atlas initiative, which aims to provide comprehensive mapping of the human proteome. This mapping is essential for facilitating scientific discovery and advancing knowledge in various fields of biology and medicine. Atlas Antibodies leverages data-driven insights to empower scientific advancements globally, making significant contributions to the life sciences community.